Status:
COMPLETED
Arsenic Exposure and Lung Cancer Incidence
Lead Sponsor:
University of Rome Tor Vergata
Conditions:
Incident Cases of Lung Cancer (Code ICD-O C340-C349)
Eligibility:
All Genders
Brief Summary
Aim of the study was to assess any associations between chronic exposure by drinking water to Arsenic and onset of lung cancer, using a retrospective cohort study design. Incident cases of lung cance...
Detailed Description
Arsenic and its compounds were classified as human carcinogens by IARC, because of their role in the onset and the progression of several neoplasms: liver, lung, bladder, prostate and skin cancer. If ...
Eligibility Criteria
Inclusion
- From 1st January 2006 to 31st December 2012 all the inhabitants, residing in one of the 60 municipalities of Viterbo Province were enrolled.
Exclusion
- No exclusion criteria were applied
Key Trial Info
Start Date :
January 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 18 2019
Estimated Enrollment :
314000 Patients enrolled
Trial Details
Trial ID
NCT04125381
Start Date
January 14 2019
End Date
March 18 2019
Last Update
October 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Registry Viterbo Province
Viterbo, Italy, 01100